"CEOs need trusted, objective sounding boards who can identify first-hand with trade-offs executives experience in balancing the needs of investors customers, employees and their own personal lives. BioPharma Consultants can always directly relate to my experiences and provide sound insights and solutions that cut to the heart of my issues."

- Gary Pace, Chairman,
Transition Pharmaceuticals


Representative Consulting Clients and Operating Experience

Biotechnology, Pharmaceutical and Chemistry
Axcan Pharmaceuticals
Galleon Pharmaceuticals
Glaxo, Inc.
Glaxo Wellcome, Inc.
Glaxo Wellcome plc
GlaxoSmithKline, Inc.
GlaxoSmithKline plc
KEJ Pharmaceuticals
Oriel Therapeutics
Oxford GlycoSciences Plc (UK)
Peninsula Pharmaceuticals
Protez Pharmaceuticals
The Procter & Gamble Company
SmithKline Beecham
Shire Pharmaceuticals
Synthon Pharmaceuticals

Device and Diagnostic Companies
Invitrox Inc.

Information Technology
BioSignia Pharmaceutical Technology Group

Venture Capital, Investment Bankers and Financial Institutions
J.P. Morgan Partners
Perseus Soros
Thomas, Knight, Trent, King & Company

BioPharma has many contacts with VCs in US and Europe. In addition, we have supported due diligence activities for the following VCs:
JP Morgan Partners
and Perseus Soros